Clinical trials of Korean natural medicine approved by U.S. FDA

Published: 2013-04-10 06:57:00

Updated: 2013-04-10 06:57:00

Yungjin Pharmaceutical said Monday it has received approval from the U.S. Food and Drug Administration on Apr. 5 to conduct advance clinical studies of a natural medicine for the treatment of chronic obstructive pulmonary disease (COPD), an under-diagnosed, progressive, irreversible lung disease....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK